Vizzia Technologies Expands New Healthcare RTLS Partnerships & Solutions
Innovative Tech Utilizes AI/ML, IoT/BLE Devices, and Digital WhiteboardsATLANTA, GA / ACCESSWIRE / July 11, 2023 / Vizzia Technologies, a...
Financial
Vizzia Technologies Expands New Healthcare RTLS Partnerships & Solutions
Innovative Tech Utilizes AI/ML, IoT/BLE Devices, and Digital WhiteboardsATLANTA, GA / ACCESSWIRE / July 11, 2023 / Vizzia Technologies, a...
Eterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directors
CAMBRIDGE, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science...
McClintock and Amfora Form Strategic Collaboration to Leverage AI to Improve Protein Content of Soy
SAN FRANCISCO, July 11, 2023 (GLOBE NEWSWIRE) -- Artificial intelligence and machine learning innovator McClintock LLC has entered into a...
New Disease Modifying Drug for Alzheimer’s Disease Fully Approved by FDA, Highlighting the Crucial Role for Cognetivity in Early Detection and Monitoring
Vital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetivity Neurosciences' AI CognICA technology poised to play pivotal...
Oxford University scientists’ AI diagnostic test accurately identifies known respiratory viruses in minutes
Breakthrough in diagnostics testing enables ‘facial recognition for germs’ Collaboration with John Radcliffe Hospital used AI to identify respiratory viruses...
Cerevance Announces Presentation at the Alzheimer’s Association International Conference
BOSTON, July 10, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel...
Advanced Health Intelligence Ltd Announces Implementation of ADS Ratio Change
NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- Advanced Health Intelligence Ltd (ASX/NASDAQ:AHI) (“Advanced Health Intelligence”, “AHI” or the “Company”)...
BioXcel Therapeutics Announces Positive Topline Results From TRANQUILITY II Phase 3 Trial of BXCL501 for Acute Treatment of Alzheimer’s Disease-Related Agitation
Trial met primary endpoint with the 60 mcg dose, with BXCL501 demonstrating a statistically significant 39% greater reduction in PEC...
Press Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease
Vaccines Investor EventVaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease Sanofi reaffirms ambition to...
Cerevance Announces Presentation at the XVI European Meeting on Glial Cells in Health and Disease
BOSTON, June 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel...
BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
Westport, CT, June 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology...
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
EAGAN, Minn., June 27, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence...
Anavex Life Sciences and Partex Group Announce Strategic Partnership to Leverage AI for Drug Development and Healthcare Sales Marketing Building a Patient-Centric Digital Ecosystem
Anavex and Partex agreed to enter into a strategic partnership to leverage Partex’s proprietary AI (Artificial Intelligence) technology for Anavex’s...
Cerevance Announces Presentation at the Gordon Research Conference: Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases
BOSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel...
OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe
Patent EP 3 332 028 B1 granted by the European Patent Office covers the identification and use of genomic variants...
Volta Medical Announces Initiation of RESTART Clinical Trial for Treatment of Repeat Atrial Fibrillation
Interventional study to evaluate long term outcomes of Volta’s AI solution-supported ablation in recurrent-AF patients who failed previous ablationInternational, multi-center...
Smart for Life Releases Corporate Video on Roger Conley Wood
Video Represents Latest in the Company’s “Director’s Forum” Series – Observations from the Company’s Independent DirectorsMIAMI, June 21, 2023 (GLOBE...
23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks
With millions of Americans experiencing mental health symptoms, 23andMe+ members now have exclusive access to four mental health reports to...
Icario Names Julia Zhang Chief Technology Officer
Teladoc Health and Humana Veteran Will Lead the Company’s Technology, Product Development, and Data Analytics Functions Julia Zhang, Chief Technology...